Hormonal contraception and HIV: An unanswered question

The Lancet Infectious Diseases

Volumn 12, Issue 1, 2012, Pages 2-3

  Morrison, Charles S ^a   Nanda, Kavita ^a  

^a FAMILY HEALTH INTERNATIONAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MEDROXYPROGESTERONE ACETATE;

FOLLOW UP; HORMONAL CONTRACEPTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; LETTER; LOW BIRTH WEIGHT; MATERNAL MORTALITY; MORBIDITY; NONHUMAN; PRIORITY JOURNAL; SELF REPORT; SOCIAL STATUS; VIRUS TRANSMISSION; WOMEN'S HEALTH;

CONTRACEPTIVES, ORAL, HORMONAL; FEMALE; HIV SEROPOSITIVITY; HIV-1; HUMANS; MALE;

EID: 84155162905     PISSN: 14733099     EISSN: 14744457     Source Type: Journal    
DOI: 10.1016/S1473-3099(11)70254-7     Document Type: Letter

References (15)

1. Joint UN Programme on HIV/AIDS (UNAIDS) Global report: UNAIDS report on the global AIDS epidemic 2010. Geneva: UNAIDS, 2010.
2. Population and HIV/AIDS 2007. (Wall chart) 2008, UN Department of Economic and Social Affairs, Population Division, UN, New York.
3. Plummer FA, Simonsen JN, Cameron DW, et al. Cofactors in male-female sexual transmission of human immunodeficiency virus type 1. J Infect Dis 1991, 163:233-239.
4. Heffron R, Donnell D, Rees H, et al. Use of hormonal contraceptives and risk of HIV-1 transmission: a prospective cohort study. Lancet Infect Dis 2011, pubished online Oct 4, 2011. 10.1016/S1473-3099(11)70247-X.
5. Morrison CS, Turner AN, Jones LB Highly effective contraception and acquisition of HIV and other sexually transmitted infections. Best Pract Res Clin Obstet Gynaecol 2009, 23:263-284.
6. Morrison CS, Chen PL, Kwok C, et al. Hormonal contraception and HIV acquisition: reanalysis using marginal structural modeling. AIDS 2010, 24:1778-1781.
7. Watson-Jones D, Baisley K, Weiss HA, et al. Risk factors for HIV incidence in women participating in an HSV suppressive treatment trial in Tanzania. AIDS 2009, 23:415-422.
8. Baeten JM, Benki S, Chohan V, et al. Hormonal contraceptive use, herpes simplex virus infection, and risk of HIV-1 acquisition among Kenyan women. AIDS 2007, 21:1771-1777.
9. Marx PA, Spira AI, Gettie A, et al. Progesterone implants enhance SIV vaginal transmission and early virus load. Nat Med 1996, 2:1084-1089.
10. Trunova N, Tsai L, Tung S, et al. Progestin-based contraceptive suppresses cellular immune responses in SHIV-infected rhesus macaques. Virology 2006, 352:169-177.
11. Hel Z, Stringer E, Mestecky J Sex steroid hormones, hormonal contraception, and the immunobiology of human immunodeficiency virus-1 infection. Endocr Rev 2010, 31:79-97.
12. Ghanem KG, Shah N, Klein RS, et al. Influence of sex hormones, HIV status, and concomitant sexually transmitted infection on cervicovaginal inflammation. J Infect Dis 2005, 191:358-366.
13. Comparison of female to male and male to female transmission of HIV in 563 stable couples. BMJ 1992, 304:809-813. European Study Group on Heterosexual Transmission of HIV.
14. Mugo NR, Heffron R, Donnell D, et al. Increased risk of HIV-1 transmission in pregnancy: a prospective study among African HIV-1-serodiscordant couples. AIDS 2011, 25:1887-1895.
15. Medical Eligibility Criteria for Contraceptive Use 2010, WHO Department of Reproductive Health, WHO, Geneva. 4th edn.